SLC3A2 and malignant colon neoplasm: Studies using immune-competent mouse models injected with mouse colon cancer cell lines and treated with a CD98hc-directed ADC able to recognize the murine protein will help in evaluating the toxicity and efficacy of the ADC in a more complete physiological context.